The electrolyte exclusion effect is the critical concept that explains why your patient’s sodium result can differ dramatically depending on the type of ion‑selective electrode (ISE) assay used. In lipemic or hyperproteinemic samples, indirect ISE methods produce falsely low electrolyte values—classic pseudohyponatremia—because they dilute a fixed total volume of plasma that contains less electrolyte‑bearing water than expected. Direct ISE methods circumvent this by measuring electrolyte activity directly in the undiluted plasma water phase, yielding a result that reflects the true physiologic state.
The root cause is simple: indirect ISE assumes your patient’s plasma is 93% water. When excess lipids or proteins displace that water, the dilution step becomes inaccurate. Direct ISE sidesteps the problem entirely by never diluting the sample—it measures what is actually present in the water phase.
The Physics Behind the Exclusion Effect
Plasma is Not Just Water
Normal plasma consists of approximately 93% water and 7% non‑aqueous solids—predominantly proteins and lipids.
Electrolytes like sodium and potassium are dissolved exclusively in the water phase.
They do not partition into the solid/lipid fraction.
The Dilution Assumption in Indirect ISE
Indirect ISE analyzers are built on a fixed‑volume sample pipetting principle.
The instrument draws up a specified volume of whole plasma and mixes it with a low‑ionic‑strength diluent.
The calculation to convert the measured signal into a concentration assumes that 93% of that volume is water containing the electrolytes.
This is typically handled by an internal calibration factor that aligns the results with flame photometry (the classic reference method).
How Elevated Solids Skew the Measurement
When a patient has severe hyperlipidemia or hyperproteinemia (e.g., multiple myeloma), the plasma water fraction may fall to 80% or even lower.
The indirect ISE still pipettes the same total volume, but now a smaller fraction of that volume is water.
Less water means fewer electrolyte ions are delivered into the diluent, causing the instrument to report a falsely low concentration per litre of total plasma.
This is the core of the electrolyte exclusion effect and the direct cause of pseudohyponatremia and pseudohypokalemia.
Direct ISE: A Different Measurement Principle
Undiluted Analysis Avoids Volume Displacement
A direct ISE introduces undiluted sample straight onto the electrode surface.
The electrode responds to ion activity strictly within the plasma water phase, exactly where the electrolytes reside.
No matter how much lipid or protein is present, the measurement reflects the true sodium activity bathing cell membranes—the physiologically active concentration.
Solvent displacement by solids becomes irrelevant.
Activity vs. Concentration and the 0.93 Factor
Direct ISE inherently measures activity per kilogram of water, not concentration per litre of total plasma.
In a normal sample with 93% water, the direct ISE reading (in mmol/L of plasma water) is roughly 7% higher than the indirect ISE reading (in mmol/L of total plasma).
To harmonise these numbers, many laboratories apply a standard conversion factor of 0.93 (or a similar instrument‑specific coefficient) to direct ISE results.
This factor works perfectly for normal samples.
In a lipemic or hyperproteinemic sample, however, the uncorrected direct ISE value remains accurate; applying the 0.93 factor to an abnormal sample would only shift a true value, while the indirect ISE result is already artefactually depressed.
That is why point‑of‑care blood gas analyzers and many intensive‑care instruments—which use direct ISE—often report sodium values that disagree with the main chemistry lab if not properly harmonised.
Understanding the Discrepancy in Clinical Context
Pseudohyponatremia and Misdiagnosis
A classic scenario: a patient with severe hypertriglyceridemia has a lab sodium of 125 mmol/L from an indirect ISE but is clinically asymptomatic.
A direct ISE on the same sample shows a sodium of 140 mmol/L.
The indirect result is pseudohyponatremia—no true sodium deficit exists.
Misinterpreting this can lead to dangerous fluid restriction or hypertonic saline administration.
When to Trust Direct ISE
In any condition that increases plasma solids, direct ISE provides the true clinically actionable sodium because it measures what the body’s water compartments actually “see.”
Guidelines from clinical chemistry bodies advise confirming unexpected low electrolytes in such patients using a direct ISE method (blood gas analyser) or after centrifuging the sample to remove the offending solids.
The Trade‑offs and Pitfalls of ISE Methodologies
Throughput vs. Accuracy in Abnormal Samples
Indirect ISE is the workhorse of large‑volume clinical chemistry analysers because it offers high throughput, minimal electrode fouling, and long reagent stability.
The trade‑off is a systematic vulnerability to volume‑displacement errors in any sample that deviates from the 93% water assumption.
The Correction Factor Confusion
Direct ISE is robust against matrix effects, but its results must be reported within appropriate reference intervals.
If a lab uses a 0.93 factor, clinicians must understand that the direct ISE number still represents plasma water activity, not a simple conversion to “total plasma” concentration when solids are abnormal.
Reporting both uncorrected and corrected values is technically possible but risks creating confusion at the point of care.
Practical Limitations
Not every facility has a direct ISE readily available outside of blood gas analysers.
When only indirect ISE is accessible, ultracentrifugation or lipid‑clearing agents can remove the interference, but these are time‑consuming and not always practical.
Point‑of‑care direct ISE devices offer speed, yet they carry their own calibration and quality control challenges.
How to Apply This Knowledge to Your Clinical Decisions
The best method depends on the question you need to answer. Use the following priorities to guide your thinking.
- If your primary focus is diagnosing a true sodium disturbance in a patient with known hyperlipidemia or hyperproteinemia: Trust the direct ISE result from a blood gas analyser; the indirect ISE sodium is likely pseudohyponatremia and should not guide therapy.
- If your primary focus is monitoring routine electrolytes in a general population without protein or lipid abnormalities: Indirect ISE is perfectly adequate and offers cost‑effective, high‑throughput testing that aligns with decades of reference interval data.
- If your primary focus is developing or validating an IVD assay: Account for the water‑displacement effect in calibrator matrices, use aqueous‑based materials that mimic 93% water content, and clearly document whether results are being reported as “total plasma” or “plasma water” concentrations to avoid clinical misinterpretation.
Understanding the electrolyte exclusion effect transforms a confusing laboratory discrepancy into a clear, predictable physical phenomenon—ensuring that the right number guides the right clinical decision.
Summary Table:
| Comparison Feature | Direct ISE | Indirect ISE |
|---|---|---|
| Sample Preparation | Undiluted plasma/whole blood | Fixed-volume dilution with diluent |
| Plasma Water Assumption | None (measures activity directly in water phase) | Assumes fixed 93% plasma water content |
| Impact of Lipids/Proteins | Unaffected; reflects true physiological state | Falsely low results (Pseudohyponatremia) |
| Measurement Output | Electrolyte activity (plasma water concentration) | Total plasma electrolyte concentration |
| Primary Application | Point-of-care (POC), blood gas, critical care | High-throughput core laboratory analysers |
Enhance Your Diagnostic Accuracy with CamelBio
Developing or optimizing ISE electrolyte assays for complex clinical matrices? CamelBio provides diagnostic manufacturers, clinical laboratories, and research institutes with one-stop access to premium IVD raw materials, technical services, and expert consulting—covering every stage of your product lifecycle from concept to clinic.
Whether you need assistance overcoming matrix interferences, formulating stable calibrators, or validating assay performance, our team is ready to support your success. Contact CamelBio today to discuss your technical and raw material requirements!